|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on July 29, 2005
Department of Biochemistry NWI 161, Radboud University Nijmegen, Nijmegen NL-6500 HB
Corresponding Author: j.raats{at}ncmls.ru.nl
Todays research demands fast identification of potential diagnostic and therapeutic targets. We describe a novel phage display strategy to identify disease-related proteins that are specifically expressed in a certain (diseased) tissue or cell. Phages displaying antibody fragments are selected on complex protein mixtures in a two-step manner, combining subtractive selection in solution with further enrichment of specific phages on two-dimensional western blots. Targets recognized by the resulting recombinant antibodies are immunoaffinity purified and identified by mass spectrometry. We used antibody fragment libraries from autoimmune patients to discover apoptosis-specific and disease-related targets. One of the three identified targets is the U1-70K protein, a marker for SLE overlap disease. Interestingly, the epitope on U1-70K, recognized by the selected recombinant antibody, is shown to be apoptosis-dependent, and such epitopes are believed to be involved in breaking tolerance to self-antigens. The other two proteins are identified as PSF / p54nrb and hnRNP C.
Revised on September 22, 2005
Accepted on October 31, 2005
A novel subtractive antibody phage display method to discover disease markers
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
D. Saerens, G. H. Ghassabeh, and S. Muyldermans Antibody technology in proteomics Brief Funct Genomic Proteomic, July 1, 2008; 7(4): 275 - 282. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| All ASBMB Journals | Journal of Biological Chemistry |
| Journal of Lipid Research | ASBMB Today |